SCM
Soleus Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-785,546
| Closed | -$8.14M | – | 92 |
|
|
2024
Q3 | $8.14M | Sell |
785,546
-14,000
| -2% | -$145K | 0.63% | 41 |
|
|
2024
Q2 | $10.4M | Buy |
799,546
+219,000
| +38% | +$2.84M | 0.91% | 35 |
|
|
2024
Q1 | $10.1M | Buy |
+580,546
| New | +$10.1M | 0.75% | 38 |
|
|
2023
Q2 | – | Sell |
-116,514
| Closed | -$4.71M | – | 102 |
|
|
2023
Q1 | $4.71M | Sell |
116,514
-21,300
| -15% | -$861K | 0.49% | 51 |
|
|
2022
Q4 | $6.41M | Buy |
137,814
+14,800
| +12% | +$688K | 0.92% | 32 |
|
|
2022
Q3 | $6.38M | Buy |
123,014
+23,014
| +23% | +$1.19M | 0.87% | 36 |
|
|
2022
Q2 | $4.73M | Sell |
100,000
-102,485
| -51% | -$4.84M | 0.74% | 40 |
|
|
2022
Q1 | $14.4M | Sell |
202,485
-115,790
| -36% | -$8.24M | 1.86% | 18 |
|
|
2021
Q4 | $23.8M | Buy |
318,275
+135,875
| +74% | +$10.2M | 2.38% | 7 |
|
|
2021
Q3 | $10.4M | Buy |
+182,400
| New | +$10.4M | 1.61% | 17 |
|
|
2020
Q4 | – | Sell |
-11,500
| Closed | -$526K | – | 70 |
|
|
2020
Q3 | $526K | Hold |
11,500
| – | – | 0.28% | 54 |
|
|
2020
Q2 | $577K | Buy |
11,500
+900
| +8% | +$45.2K | 0.33% | 52 |
|
|
2020
Q1 | $545K | Buy |
+10,600
| New | +$545K | 0.63% | 32 |
|